Recent Updates
Recently added Catalysts
MNPR Positive Sentiment Score: 65/100

Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference

Tuesday, December 3, 2024 1 min read
Key Takeaway: Monopar Therapeutics Inc. will participate in the 36th Annual Piper Sandler Healthcare Conference, featuring a fireside chat by CEO Chandler Robinson. Scheduled for December 5, 2024, the event will take place at the Lotte New York Palace. Monopar is recognized for its development of treatments for Wilson disease and advanced cancers, which could attract investor interest.

Market Sentiment Analysis

POSITIVE FACTORS

  • Monopar Therapeutics is participating in a prestigious healthcare conference.
  • The company is focused on innovative treatments for unmet medical needs.
  • CEO Chandler Robinson will discuss the company's future directly with potential investors.

Full Press Release Details

WILMETTE, Ill., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will participate in a fireside chat along with one-on-one meetings at the 36th Annual Piper Sandler Healthcare Conference.
Presentation Details:
Date: December 5, 2024
Time: 10:30-10:55 am Eastern Time
Location: Lotte New York Palace, NY, NY
About Monopar Therapeutics Inc.
Monopar Therapeutics is a clinical-stage biotechnology company with late-stage ALXN-1840 for Wilson disease, and radiopharma programs including Phase 1-stage MNPR-101-Zr for imaging advanced cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac225 for the treatment of advanced cancers. For more information, visit: www.monopartx.com.
Monopar Therapeutics Inc.
Karthik Radhakrishnan
Chief Financial Officer
karthik@monopartx.com
Follow Monopar on social media for updates:
Twitter: @MonoparTx  LinkedIn: Monopar Therapeutics

Frequently Asked Questions

When is Monopar's presentation at the Piper Sandler Conference?

Monopar's presentation is on December 5, 2024, from 10:30 to 10:55 am ET.

Where will the Piper Sandler Healthcare Conference be held?

The conference will take place at the Lotte New York Palace, NY, NY.

What is Monopar Therapeutics focused on?

Monopar Therapeutics develops innovative treatments for unmet medical needs.

What is ALXN-1840 used for?

ALXN-1840 is a late-stage treatment for Wilson disease.

How can I learn more about Monopar Therapeutics?

Visit their website at www.monopartx.com for more information.

Tags: MNPR Viatris Investor Conferences Healthcare Monopar Therapeutics Piper Sandler healthcare conference Chandler Robinson
Last updated: Dec 3, 2024